The prevalence and diversity of fungi in respiratory samples of cystic fibrosis patients – a Dutch, nationwide, prospective, multicentre study

T. Engel (Nijmegen, Netherlands), L. Slabbers (Nijmegen, Netherlands), C. De Jong (Nijmegen, Netherlands), W. Melchers (Nijmegen, Netherlands), F. Hagen (Nijmegen, Netherlands), P. Verweij (Nijmegen, Netherlands), P. Merkus (Nijmegen, Netherlands), J. Meis (Nijmegen, Netherlands)

Source: International Congress 2018 – Latest developments in cystic fibrosis
Session: Latest developments in cystic fibrosis
Session type: Poster Discussion
Number: 3410
Disease area: Respiratory infections

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Engel (Nijmegen, Netherlands), L. Slabbers (Nijmegen, Netherlands), C. De Jong (Nijmegen, Netherlands), W. Melchers (Nijmegen, Netherlands), F. Hagen (Nijmegen, Netherlands), P. Verweij (Nijmegen, Netherlands), P. Merkus (Nijmegen, Netherlands), J. Meis (Nijmegen, Netherlands). The prevalence and diversity of fungi in respiratory samples of cystic fibrosis patients – a Dutch, nationwide, prospective, multicentre study. 3410

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
A multicentre, observational cohort study to determine the efficacy and safety of lumacaftor/ivacaftor in patients with severe lung disease and cystic fibrosis
Source: International Congress 2019 – Advances in care and monitoring of cystic fibrosis
Year: 2019



Cross-sectional, observational study to estimate the prevalence of the eosinophilic phenotype for Brazilian patients with severe asthma: the BRAEOS study
Source: Virtual Congress 2020 – Clinical characteristics and diagnostic tools for phenotyping asthma and COPD
Year: 2020


PEGASUS - the effects of commercial air travel on patients suffering from pulmonary hypertension - a prospective, multicenter, multinational study
Source: International Congress 2018 – Clinical aspects of pulmonary hypertension
Year: 2018

Characteristics and clinical management of IPF patients in Spain: prospective, observational, multicentric study (OASIS study).
Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Year: 2020


Efficacy and safety of nintedanib in a Greek multicentre idiopathic pulmonary fibrosis registry: a retrospective, observational, cohort study
Source: ERJ Open Res, 6 (1) 00172-2019; 10.1183/23120541.00172-2019
Year: 2020



Increasing bronchiectasis prevalence in Germany, 2009–2017: a population-based cohort study
Source: Eur Respir J, 54 (6) 1900499; 10.1183/13993003.00499-2019
Year: 2019



A multicentre cohort study on the association between common markers of asthma and the incidence of COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 295s
Year: 2006

Health resource utilisation due to IPF exacerbations in Spain: prospective, observational, multicentric study (OASIS study)
Source: Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis
Year: 2020


Economic impact of IPF exacerbations in Spain: prospective, observational, multicentric study (OASIS study)
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021


Clinical phenotypes of extrapulmonary sarcoidosis: an analysis of a French, multi-ethnic, multicentre cohort
Source: Eur Respir J, 57 (4) 2001160; 10.1183/13993003.01160-2020
Year: 2021



Development of antibiotic-resistance in P. aeruginosa obtained from bronchiectasis patients: a multicenter prospective observational study
Source: International Congress 2018 – The airway microbiome across the spectrum of airway disease
Year: 2018



Higher frequency of comorbidities in fully vaccinated patients admitted to the ICU due to severe COVID-19: a prospective, multicentre, observational study
Source: Eur Respir J, 59 (2) 2102275; 10.1183/13993003.02275-2021
Year: 2022



Predictors for detecting chronic respiratory diseases in population surveys: a pilot study for RESPIRE 4CCORD study
Source: Virtual Congress 2021 – Epidemiology and burden of tuberculosis and other lung diseases
Year: 2021


Survival estimates in European cystic fibrosis patients and the impact of socioeconomic factors: a retrospective registry cohort study
Source: Eur Respir J, 58 (3) 2002288; 10.1183/13993003.02288-2020
Year: 2021



Etiology and clinical characteristics of bronchiectasis in Taiwan: a multi-center cohort study
Source: International Congress 2019 – Tuberculosis epidemiology, bronchiectasis, other infections and spirometry
Year: 2019


Monitoring physical activity in COPD patients – a monocentric, prospective cohort study
Source: Virtual Congress 2020 – Clinical and functional evaluation of COPD
Year: 2020


REALizing and improving management of COPD in China: A prospective observational study
Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data
Year: 2021


Neomacrolides in the treatment of patients with severe asthma and/or bronchiectasis: A retrospective observational study
Source: Annual Congress 2010 - Aspects of severe asthma
Year: 2010


Characteristics of subjects susceptible to exacerbation-like respiratory events in a population-based cohort: Canadian cohort obstructive lung disease (CanCOLD) study
Source: International Congress 2014 – Longitudinal studies of respiratory disease
Year: 2014


Characteristics of COPD patients from primary care enrolled in a prospective multicenter cohort study
Source: Annual Congress 2010 - Comorbidity in obstructive airway disease
Year: 2010